Vice President, Clinical Development
EligibilityRemote, United States only
Languages
$366k–$398k/yr
Company profile
Spyre Therapeutics is a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.
9 observationsLast observed
3 open roles